Lantz Financial LLC Grows Holdings in Colgate-Palmolive (NYSE:CL)

Lantz Financial LLC raised its position in Colgate-Palmolive (NYSE:CL) by 0.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 20,140 shares of the company’s stock after buying an additional 122 shares during the period. Lantz Financial LLC’s holdings in Colgate-Palmolive were worth $1,831,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. Peak Financial Advisors LLC purchased a new stake in Colgate-Palmolive during the fourth quarter worth about $1,315,000. Gordian Advisors LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $602,000. Carrera Capital Advisors raised its holdings in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares during the period. Fiduciary Alliance LLC purchased a new stake in Colgate-Palmolive in the fourth quarter worth $4,066,000. Finally, Vontobel Holding Ltd. raised its stake in shares of Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after buying an additional 550,750 shares during the period. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on CL shares. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Stifel Nicolaus cut their price objective on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. Finally, TD Cowen dropped their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Trading Down 0.0 %

Shares of CL opened at $87.88 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 1-year low of $80.03 and a 1-year high of $109.30. The company has a market capitalization of $71.79 billion, a P/E ratio of 25.18, a P/E/G ratio of 3.59 and a beta of 0.44. The firm’s 50 day simple moving average is $91.81 and its 200 day simple moving average is $97.44.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.